True North Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21M Sell
10,236
-402
-4% -$49.7K 0.14% 98
2025
Q4
$1.34M Sell
10,638
-785
-7% -$102K 0.17% 89
2025
Q3
$1.67M Sell
11,423
-911
-7% -$138K 0.27% 59
2025
Q2
$1.92M Sell
12,334
-3,775
-23% -$599K 0.37% 58
2025
Q1
$2.65M Sell
16,109
-2,604
-14% -$433K 0.47% 52
2024
Q4
$3.05M Buy
+18,713
New +$3.35M 0.72% 34
2022
Q1
Sell
-32,294
Closed -$7.88M 242
2021
Q4
$7.88M Buy
32,294
+1,675
+5% +$367K 1.33% 13
2021
Q3
$5.94M Buy
30,619
+411
+1% +$82.9K 1.17% 17
2021
Q2
$5.63M Buy
30,208
+166
+0.6% +$28.8K 1.17% 16
2021
Q1
$4.73M Sell
30,042
-9
-0% -$1.43K 1.12% 15
2020
Q4
$4.97M Sell
30,051
-170
-0.6% -$27.6K 1.28% 15
2020
Q3
$5M Sell
30,221
-29,779
-50% -$4.58M 1.46% 13
2020
Q2
$8.22M Sell
60,000
-1
-0% -$131 1.98% 12
2020
Q1
$7.06M Hold
60,001
2.41% 13
2019
Q4
$7.94M Buy
+60,001
New +$7.46M 2.23% 14

Other funds holding ZTS

True North Advisors's ZTS Position: Q1 2026 in Review

True North Advisors reduced its Zoetis (ZTS) stake by 3.8% in Q1 2026, selling an estimated $49.7K and leaving 10,236 shares worth $1.21M. The position accounts for 0.14% of the portfolio, ranked #98.

True North Advisors first reported a position in ZTS in Q4 2019 and has held it in 15 quarters since. The position peaked at $8.22M in Q2 2020. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • True North Advisors held 10,236 shares of Zoetis worth $1.21M as of Q1 2026.
  • True North Advisors sold 402 Zoetis shares in Q1 2026, an estimated $49.7K.
  • Zoetis made up 0.14% of True North Advisors's portfolio in Q1 2026, its #98 holding.
  • True North Advisors first reported a position in Zoetis in Q4 2019 and has held it in 15 quarters since.
  • True North Advisors's Zoetis position peaked at $8.22M in Q2 2020.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on True North Advisors's 13F filing for Q1 2026, filed 7 May 2026.